⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for bone metastases in subjects with advanced cancer or multiple myeloma

Every month we try and update this database with for bone metastases in subjects with advanced cancer or multiple myeloma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesNCT00104650
Bone Metastases...
Bone Metastases...
Bone Metastases...
AMG 162 180 mg ...
IV Bisphosphona...
AMG 162- 180 mg...
18 Years - Amgen
Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyNCT00950911
Bone Metastases...
Bone Metastases...
Bone Metastases...
amg 162
18 Years - Amgen
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesNCT00104650
Bone Metastases...
Bone Metastases...
Bone Metastases...
AMG 162 180 mg ...
IV Bisphosphona...
AMG 162- 180 mg...
18 Years - Amgen
Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyNCT00950911
Bone Metastases...
Bone Metastases...
Bone Metastases...
amg 162
18 Years - Amgen
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: